Amyotrophic lateral sclerosis and neurodegenerative diseases: A Mendelian randomization study
- PMID: 40550045
- PMCID: PMC12187284
- DOI: 10.1097/MD.0000000000042847
Amyotrophic lateral sclerosis and neurodegenerative diseases: A Mendelian randomization study
Abstract
In this study, we used the Mendelian randomization (MR) method to systematically examine whether there is a bidirectional causal relationship between amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD), Parkinson's disease (PD), frontotemporal dementia (FTD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB). We analyzed data from 6,44,924 participants using MR to evaluate causality. We employed inverse variance weighted and MR-Egger regression tests for MR analysis. Additionally, we performed sensitivity analyses using the MR-Egger test and Mendelian Randomization Pleiotropy RESidual Sum and Outlier. The inverse variance weighted analysis found no evidence of a risk effect between ALS and the neurodegenerative diseases AD, PD, FTD, MSA, and DLB. However, the MR-Egger analysis showed that both AD (odds ratio: 1.079, 95% confidence interval: 1.017-1.145, P = .029) and PD (odds ratio: 1.210, 95% confidence interval: 1.046-1.401, P = .020) have a risk effect on ALS, indicating that AD and PD increase the risk of ALS. Our MR analysis suggests that AD and PD may have a potential causal relationship with ALS. Conversely, ALS does not appear to have a causal relationship with the other neurodegenerative diseases examined (FTD, MSA, DLB).
Keywords: Alzheimer’s disease; Mendelian randomization study; Parkinson’s disease; amyotrophic lateral sclerosis; dementia with Lewy bodies; frontotemporal dementia; multiple system atrophy.
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures


Similar articles
-
Bidirectional Causal Relationship Between Myopia and Neurodegenerative Diseases: Two-Sample Mendelian Randomization Analyses.Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-19. doi: 10.12968/hmed.2025.0183. Epub 2025 Jun 18. Br J Hosp Med (Lond). 2025. PMID: 40554439
-
Genetically Predict Diet-derived Antioxidants and Risk of Neurodegenerative Diseases Among Individuals of European Descent: A Mendelian Randomization Study.Brain Behav. 2025 Aug;15(8):e70766. doi: 10.1002/brb3.70766. Brain Behav. 2025. PMID: 40792523 Free PMC article.
-
A Genome-wide study on the genetic and causal effects of smoking in neurodegeneration.J Transl Med. 2025 Jul 4;23(1):743. doi: 10.1186/s12967-025-06688-9. J Transl Med. 2025. PMID: 40615926 Free PMC article.
-
Pseudobulbar affect in neurodegenerative diseases: A systematic review and meta-analysis.J Clin Neurosci. 2022 Jun;100:100-107. doi: 10.1016/j.jocn.2022.04.009. Epub 2022 Apr 15. J Clin Neurosci. 2022. PMID: 35436682
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Cochrane Database Syst Rev. 2012. PMID: 22419314 Free PMC article.
References
-
- Fang X, Cao X, Mei Q, Zhang J, Wu S. Research progress of amyotrophic lateral sclerosis overlaps with other neurodegenerative diseases. Chin J Neurol. 2015;48:428–30.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous